The lancet oncology

• Latest
• Best
• Search…

• The lancet oncology · Apr 2015

  First biosimilar drug approved in the USA.

  no abstract available

  read on… mark as read…

• The lancet oncology · Apr 2015

  Aromatase inhibitors may reduce endometrial cancer risk.

  no abstract available

  read on… or not…

• The lancet oncology · Apr 2015

  Correction to Lancet Oncol 2015; 16: 60, 61. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multi-centre, single-arm, phase 2 study.

  no abstract available

  expand abstract… or not…

• The lancet oncology · Apr 2015

  Sunitinib benefits patients with small-cell lung cancer.

  no abstract available

  expand abstract… mark as read…

• The lancet oncology · Mar 2015

  Randomized Controlled Trial Multicenter Study

  Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.

  The benefit or harm of trabectedin discontinuation in patients with non-progressive soft-tissue sarcoma remains unclear. We report the final analysis of a phase 2 trial investigating the clinical benefit of continuation of trabectedin treatment until progression versus interruption of therapy after six treatment cycles in patients with advanced soft-tissue sarcoma. ⋯ The French National Cancer Institute (INCa) and PharmaMar SA.

  read more… mark as read…